Viagra for women suffers another setback

Lustpille for the woman suffers new setback

02/13/2014

About 16 years ago, the groundbreaking success of the male-enhancement drug Viagra started. Since then, the pharmaceutical industry has been feverishly searching for a counterpart for women. Now the Lustpille for the woman received another setback by a US authority.

Feverish search for pleasure pill for the woman
About 16 years ago, after the US Food and Drug Administration approved the male-enhancement pill, Viagra, the pharmaceutical industry's feverish search began for a female counterpart. But now the pleasure pill for the woman suffered another setback. The US Food and Drug Administration (FDA) has asked the US company Sprout Pharmaceuticals for more in-depth research into potential side effects of its libido-boosting pill „flibanserin“. This was announced in Raleigh in the US state of North Carolina based laboratory on Tuesday.

Funds bought by German pharmaceutical company
For the company the objection of the FDA means a further setback in the now 15-year-long search for a feminine pleasure-enhancing agent. Following the successful and lucrative launch of Viagra, numerous large pharmaceutical companies such as Viagra inventor Pfizer or Procter & Gamble had plunged into this research. Small startup companies are nowadays playing in this field. Prout Pharmaceuticals bought in 2011 „flibanserin“ from the German group Boehringer Ingelheim. The Rhineland-Palatinate company had thrown the towel after a negative decision by the FDA.

Rosa Viagra with side effects
The active substance „flibanserin“ was actually developed to relieve depression. During the development, the researchers of the pharmaceutical company discovered that the substance can also increase the sense of pleasure of women. Thus, the drug should be considered „Pink Viagra“ be distributed in pharmacies, especially to give women before menopause, an increase in libido. However, studies had shown at that time that among women who took the funds, only a modest upward trend in their „sexually satisfying events“ could be recorded. In addition, side effects often occurred in studies. These included dizziness, tiredness and nausea. Occasionally insomnia, dry mouth, constipation and stress could be observed as a side effect. In addition, the clinical studies showed that the sedative effect of the substance could also increase the risk of accidents and injuries.

Female libido influenced by various factors
Even the spilled by a couple Labor Sprout could not eradicate the pitfalls of the pill apparently. Ten percent of the subjects reported in a study of the company after the daily intake of the agent from occurring drowsiness. The US Food and Drug Administration now wants to know how the pill reacts with other medicines and whether it affects the ability to drive. Experts say that one of the reasons why it is so difficult is one „female Viagra“ because the female libido is influenced by many different factors. If the FDA „flibanserin“ But if one day should approve, the remedy would be especially suitable for women who are just before the menopause and suffering from lack of sexual desire. But then Sprout Pharmaceuticals would first have to find doctors who prescribe the drug because often enough, there is still skepticism, as it was said. (Sb)

Picture credits: Martin Berk